{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:14:58Z","timestamp":1794946498531,"version":"4.9.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017119","name":"Wistar Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P40-OD-010939"],"award-info":[{"award-number":["P40-OD-010939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA272270-01"],"award-info":[{"award-number":["U01 CA272270-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["4-U24-CA-224122-02"],"award-info":[{"award-number":["4-U24-CA-224122-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KO8CA252619"],"award-info":[{"award-number":["KO8CA252619"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RGI-2001"],"award-info":[{"award-number":["RGI-2001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.xcrm.2023.101241","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:50:46Z","timestamp":1697539846000},"page":"101241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients"],"prefix":"10.1016","volume":"4","author":[{"given":"Antonia","family":"Rotolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin C.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9830-3151","authenticated-orcid":false,"given":"Matthew J.","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Kulikovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Jarocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Fraietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Diffenderfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Cengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Piviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimon","family":"Duran-Struuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-4927","authenticated-orcid":false,"given":"Nicola J.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101241_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molimm.2020.12.015","article-title":"Exploiting CD1-restricted T\u00a0cells for clinical benefit","volume":"132","author":"Exley","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ni.3298","article-title":"The burgeoning family of unconventional T\u00a0cells","volume":"16","author":"Godfrey","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-immunol-032414-112008","article-title":"The Immunology of CD1- and MR1-Restricted T Cells","volume":"34","author":"Mori","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib4","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2013-11-541235","article-title":"Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy","volume":"124","author":"Heczey","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ccell.2018.08.017","article-title":"Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting","volume":"34","author":"Rotolo","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101241_bib6","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1182\/blood-2011-11-389304","article-title":"Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation","volume":"119","author":"Chaidos","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib7","first-page":"A680","article-title":"649 Phase 1\/2 study of AgenT-797, an allogeneic invariant natural killer T (iNKT) cell therapy, in subjects with moderate to severe acute respiratory distress syndrome (ARDS) secondary to SARS-CoV-2 (COVID-19)","volume":"10","author":"Purbhoo","year":"2022","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/j.xcrm.2023.101241_bib8","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2021-149712","article-title":"Allogeneic NKT Cells Expressing a CD19-Specific CAR in Patients with Relapsed or Refractory B-Cell Malignancies: An Interim Analysis","volume":"138","author":"Ramos","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood.2022016201","article-title":"Natural killer T\u00a0cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapy","volume":"141","author":"Courtney","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nri3725","article-title":"Natural killer T\u00a0cells: drivers or passengers in preventing human disease?","volume":"14","author":"Berzins","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.2019001903","article-title":"High-parametric evaluation of human invariant natural killer T\u00a0cells to delineate heterogeneity in allo- and autoimmunity","volume":"135","author":"Erkers","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib12","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of Mice and Not Men: Differences between Mouse and Human Immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1470735","article-title":"Human CD4- invariant NKT lymphocytes regulate graft versus host disease","volume":"7","author":"Coman","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2023.101241_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0684.2007.00222.x","article-title":"Invariant natural killer T\u00a0cells from rhesus macaque spleen and peripheral blood are phenotypically and functionally distinct populations","volume":"37","author":"Gansuvd","year":"2008","journal-title":"J.\u00a0Med. Primatol."},{"key":"10.1016\/j.xcrm.2023.101241_bib15","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4049\/jimmunol.171.4.1775","article-title":"NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells","volume":"171","author":"Kenna","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T\u00a0cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2023.101241_bib17","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1182\/blood-2013-08-453126","article-title":"Regulatory T\u00a0cells and natural killer T\u00a0cells for modulation of GVHD following allogeneic hematopoietic cell transplantation","volume":"122","author":"Schneidawind","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib18","first-page":"3320","article-title":"CD4+ invariant natural killer T\u00a0cells protect from murine GVHD lethality through expansion of donor CD4+ CD25+ FoxP3+ regulatory T\u00a0cells. Blood","volume":"124","author":"Schneidawind","year":"2014","journal-title":"The Journal of the American Society of Hematology"},{"key":"10.1016\/j.xcrm.2023.101241_bib19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2141.1999.01337.x","article-title":"A history of haemopoietic cell transplantation","volume":"105","author":"Thomas","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2023.101241_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1191\/0960327102ht286oa","article-title":"Overview of immune system development in the dog: comparison with humans","volume":"21","author":"Felsburg","year":"2002","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.xcrm.2023.101241_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1676615","article-title":"Establishing a model system for evaluating CAR T\u00a0cell therapy using dogs with spontaneous diffuse large B cell lymphoma","volume":"9","author":"Panjwani","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2023.101241_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ccell.2020.01.004","article-title":"Comparative Molecular Life History of Spontaneous Canine and Human Gliomas","volume":"37","author":"Amin","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101241_bib71","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1073\/pnas.1300200110","article-title":"Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T\u00a0cells","volume":"110","author":"Wen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101241_bib23","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101241_bib24","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41591-020-1074-2","article-title":"Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis","volume":"26","author":"Heczey","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101241_bib25","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1172\/JCI83476","article-title":"CD62L+ NKT cells have prolonged persistence and antitumor activity in\u00a0vivo","volume":"126","author":"Tian","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.101241_bib26","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.4049\/jimmunol.167.6.3114","article-title":"Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells","volume":"167","author":"Metelitsa","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib27","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/sj.leu.2402943","article-title":"Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells","volume":"17","author":"Metelitsa","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2023.101241_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001412","article-title":"The molecular basis for recognition of CD1d\/alpha-galactosylceramide by a human non-Valpha24 T\u00a0cell receptor","volume":"10","author":"L\u00f3pez-Sagaseta","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.xcrm.2023.101241_bib29","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.4049\/jimmunol.1100794","article-title":"NKT TCR recognition of CD1d-\u03b1-C-galactosylceramide","volume":"187","author":"Patel","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib30","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1158\/1078-0432.CCR-21-1329","article-title":"Allogeneic CAR-invariant Natural Killer T Cells Exert Potent Antitumor Effects Through Host CD8\u00a0T Cell Cross-Priming","volume":"27","author":"Simonetta","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101241_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.omto.2018.08.002","article-title":"Checkpoint Blockade Reverses Anergy in IL-13Ralpha2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas","volume":"11","author":"Yin","year":"2018","journal-title":"Mol.\u00a0Ther. Oncolytics"},{"key":"10.1016\/j.xcrm.2023.101241_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101241_bib33","doi-asserted-by":"crossref","first-page":"A09","DOI":"10.1158\/2643-3249.LYMPHOMA22-A09","article-title":"Abstract A09: Telomerase activity as a biomarker to predict outcomes of CAR T-cell therapy","volume":"3","author":"Sayed","year":"2022","journal-title":"Blood Cancer Discovery"},{"key":"10.1016\/j.xcrm.2023.101241_bib34","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2021-153183","article-title":"T-Cell Telomere Length As a Biomarker to Predict Outcome in Patients Receiving CAR-T Immunotherapy","volume":"138","author":"Tedone","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib35","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1182\/blood-2016-07-723015","article-title":"Tolerogenic interactions between CD8(+) dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts","volume":"129","author":"Hongo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/eji.200838657","article-title":"Differences in Bcl-2 expression by T-cell subsets alter their balance after in\u00a0vivo irradiation to favor CD4+Bcl-2hi NKT cells","volume":"39","author":"Yao","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00007890-199510150-00014","article-title":"Alloantigen priming after total lymphoid irradiation alters alloimmune cytokine responses","volume":"60","author":"Field","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2023.101241_bib38","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4049\/jimmunol.167.4.2087","article-title":"Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T\u00a0cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: \"natural suppressor\" cells","volume":"167","author":"Lan","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1083-8791(03)00108-3","article-title":"Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T\u00a0cells","volume":"9","author":"Lan","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.xcrm.2023.101241_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib41","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/eji.201040394","article-title":"NKT cells, Treg, and their interactions in bone marrow transplantation","volume":"40","author":"Kohrt","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib42","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1182\/blood-2011-08-371948","article-title":"Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants","volume":"119","author":"Hongo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib43","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/ajt.12914","article-title":"Requirement for interactions of natural killer T\u00a0cells and myeloid-derived suppressor cells for transplantation tolerance","volume":"14","author":"Hongo","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2023.101241_bib44","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.4049\/jimmunol.169.10.5564","article-title":"Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T\u00a0cells and clonal deletion","volume":"169","author":"Higuchi","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2009.02942.x","article-title":"The changed balance of regulatory and naive T\u00a0cells promotes tolerance after TLI and anti-T-cell antibody conditioning","volume":"10","author":"Nador","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.xcrm.2023.101241_bib46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2017.01.069","article-title":"Increased Foxp3(+)Helios(+) Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells","volume":"23","author":"Chen","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.xcrm.2023.101241_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3369","article-title":"Invariant natural killer T\u00a0cells: an innate activation scheme linked to diverse effector functions","volume":"13","author":"Brennan","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib48","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1182\/blood-2011-12-396119","article-title":"Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T\u00a0cells after experimental allogeneic bone marrow transplantation","volume":"119","author":"Robb","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib49","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/TP.0000000000000813","article-title":"Advances on Non-CD4\u00a0+ Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation","volume":"99","author":"Ligocki","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.xcrm.2023.101241_bib50","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2016-02-698241","article-title":"Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression","volume":"128","author":"Belle","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","article-title":"Engineering universal cells that evade immune detection","volume":"19","author":"Lanza","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib52","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41422-022-00745-4","article-title":"Off-the-shelf CAR T\u00a0cells to treat cancer","volume":"32","author":"Castelli","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2023.101241_bib53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2023.101241_bib54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ymthe.2022.11.019","article-title":"Mucosal-associated invariant T\u00a0cells for cancer immunotherapy","volume":"31","author":"Li","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2023.101241_bib55","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41587-022-01363-6","article-title":"Unconventional \u03b3\u03b4 T\u00a0cells \u2018the new black\u2019 in cancer therapy","volume":"40","author":"Dolgin","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2023.101241_bib56","article-title":"Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy","volume":"2","author":"Li","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2023.101241_bib57","first-page":"A305","article-title":"290 A novel iPSC-derived CAR-invariant natural killer T (iNKT) cell therapy platform for hematologic malignancies and solid tumors","volume":"10","author":"Urakami","year":"2022","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10.1016\/j.xcrm.2023.101241_bib58","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41423-021-00732-6","article-title":"Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy","volume":"18","author":"Zhang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib59","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1182\/blood.V30.6.805.805","article-title":"Marrow engraftment by allogeneic leukocytes in lethally irradiated dogs","volume":"30","author":"Storb","year":"1967","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2273","article-title":"Translation of new cancer treatments from pet dogs to humans","volume":"8","author":"Paoloni","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2023.101241_bib61","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1158\/1078-0432.CCR-15-2347","article-title":"Defining the Value of a Comparative Approach to Cancer Drug Development","volume":"22","author":"LeBlanc","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101241_bib62","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/mt.2016.173","article-title":"Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers","volume":"24","author":"Mata","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2023.101241_bib63","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.171.6.2904","article-title":"Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells","volume":"171","author":"Gansuvd","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2172-9-71","article-title":"Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide","volume":"9","author":"Croudace","year":"2008","journal-title":"BMC Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib65","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/leu.2016.281","article-title":"Pre-transplant donor CD4(-) invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease","volume":"31","author":"Rubio","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2023.101241_bib66","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/bloodadvances.2020001797","article-title":"Lingering effects of chemotherapy on mature T\u00a0cells impair proliferation","volume":"4","author":"Das","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2023.101241_bib67","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3389\/fimmu.2017.00900","article-title":"Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation","volume":"8","author":"Mavers","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib68","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1182\/blood-2014-11-612762","article-title":"Third-party CD4+ invariant natural killer T\u00a0cells protect from murine GVHD lethality","volume":"125","author":"Schneidawind","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101241_bib69","doi-asserted-by":"crossref","first-page":"eabn6563","DOI":"10.1126\/sciimmunol.abn6563","article-title":"TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells","volume":"7","author":"Delfanti","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.101241_bib70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1158\/0008-5472.CAN-03-0576","article-title":"Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts","volume":"64","author":"Davies","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101241_bib74","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.vetimm.2009.08.002","article-title":"Identification of canine natural CD3-positive T\u00a0cells expressing an invariant T-cell receptor alpha chain","volume":"132","author":"Yasuda","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.xcrm.2023.101241_bib85","doi-asserted-by":"crossref","first-page":"D1262","DOI":"10.1093\/nar\/gkab1136","article-title":"IMGT\u00ae databases, related tools and web resources through three main axes of research and development","volume":"50","author":"Manso","year":"2022","journal-title":"Nucleic acids research"},{"key":"10.1016\/j.xcrm.2023.101241_bib86","doi-asserted-by":"crossref","first-page":"D413","DOI":"10.1093\/nar\/gku1056","article-title":"IMGT\u00ae, the international ImMunoGeneTics information system\u00ae 25 years on","volume":"43","author":"Lefranc","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xcrm.2023.101241_bib87","doi-asserted-by":"crossref","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","article-title":"Ensembl 2022","volume":"50","author":"Cunningham","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xcrm.2023.101241_bib88","doi-asserted-by":"crossref","first-page":"W276","DOI":"10.1093\/nar\/gkac240","article-title":"Search and sequence analysis tools services from EMBL-EBI in 2022","volume":"50","author":"Madeira","year":"2022","journal-title":"Nucleic acids research"},{"key":"10.1016\/j.xcrm.2023.101241_bib72","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nbt0906-1065b","article-title":"The dog as a cancer model","volume":"24","author":"Khanna","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2023.101241_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100905","article-title":"Genetic re-direction of canine primary T\u00a0cells for clinical trial use in pet dogs with spontaneous cancer","volume":"2","author":"Rotolo","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2023.101241_bib75","doi-asserted-by":"crossref","first-page":"D351","DOI":"10.1093\/nar\/gky1100","article-title":"InterPro in 2019: improving coverage, classification and access to protein sequence annotations","volume":"47","author":"Mitchell","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101241_bib76","doi-asserted-by":"crossref","first-page":"D492","DOI":"10.1093\/nar\/gkp858","article-title":"The NCBI BioSystems database","volume":"38","author":"Geer","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101241_bib77","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101241_bib78","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.101241_bib79","doi-asserted-by":"crossref","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","article-title":"The Reactome Pathway Knowledgebase","volume":"46","author":"Fabregat","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101241_bib80","doi-asserted-by":"crossref","first-page":"D661","DOI":"10.1093\/nar\/gkx1064","article-title":"WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research","volume":"46","author":"Slenter","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2023.101241_bib81","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2023.101241_bib82","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"Hafemeister","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2023.101241_bib83","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fonc.2019.01172","article-title":"Telomere Length Maintenance and Its Transcriptional Regulation in Lynch Syndrome and Sporadic Colorectal Carcinoma","volume":"9","author":"Nersisyan","year":"2019","journal-title":"Front. Oncol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123004184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123004184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:15:30Z","timestamp":1778919330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123004184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":87,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2666379123004184"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101241","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101241"}}